BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1296231)

  • 1. Ursodeoxycholic acid for the treatment of cholestatic diseases.
    Poupon RE; Poupon R
    Prog Liver Dis; 1992; 10():219-38. PubMed ID: 1296231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
    Parés A; Rodés J
    Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
    [No Abstract]   [Full Text] [Related]  

  • 3. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with ursodeoxycholic acid in cholestatic liver disease.
    Van de Meeberg PC; van Erpecum KJ; van Berge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1993; 200():15-20. PubMed ID: 8016564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bile acids in liver diseases--current indications].
    Stiehl A
    Ther Umsch; 1995 Oct; 52(10):682-6. PubMed ID: 7482380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of cholestatic hepatopathies].
    Leuschner U
    Schweiz Rundsch Med Prax; 1992 Aug; 81(34):983-4. PubMed ID: 1529191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid].
    Stiehl A
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():129-30. PubMed ID: 7483696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of cholestatic liver diseases].
    Gatzen M; Pausch J
    Med Klin (Munich); 2002 Mar; 97(3):152-9. PubMed ID: 11957790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholestasis: therapeutic options].
    Beuers U; Oswald M
    Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of ursodeoxycholic acid in the treatment of hepato-biliary complications in cystic fibrosis].
    Galabert C; Lengrand D; Montet JC; Dimier JL; Chazalette JP
    Pathol Biol (Paris); 1991 Jun; 39(6):625-8. PubMed ID: 1923597
    [No Abstract]   [Full Text] [Related]  

  • 18. New therapeutical indications of ursodeoxycholic acid.
    Copaci I; Micu L; Iliescu L; Voiculescu M
    Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of cholestatic liver diseases with ursodeoxycholic acid: a new treatment principle].
    Stiehl A
    Z Gastroenterol Verh; 1991 Mar; 26():142-3. PubMed ID: 1714128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.